Compound 135
Identifiers
- Canonical SMILES:
CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1ccc(SC(F)(F)F)cc1
- IUPAC name:
N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)-4-(trifluoromethylsulfanyl)benzamide
- InChi:
InChI=1S/C30H32Cl3F3N2O4S2/c1-18(2)14-37(29(40)22-5-7-25(8-6-22)43-30(34,35)36)16-20-9-21(11-23(31)10-20)17-38(15-19(3)4)44(41,42)27-13-24(32)12-26(33)28(27)39/h5-13,18-19,39H,14-17H2,1-4H3
- InChiKey:
QVALIAVGZJQJEF-UHFFFAOYSA-N
External links
58531435 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 71 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.33 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 710.08 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 9.74 | |||
TPSA | 77.92 | |||
RB | 12 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 71 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.33 | |
WO2009152082 | 71 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.01 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5231 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.5181 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4824 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4815 | Saccharin | DB12418 | |
0.4743 | Glyburide | DB01016 | |
0.4741 | Sulfabenzamide | DB09355 | |
0.4671 | Sp-722 | DB04503 | |
0.4660 | Repinotan | DB06506 | |
0.4559 | Probenecid | DB01032 | |
0.4518 | 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide | DB03697 | |
0.4511 | CGS-27023 | DB07556 | |
0.4472 | Clorexolone | DB13617 | |
0.4453 | N-Benzyl-4-Sulfamoyl-Benzamide | DB01748 | |
0.4412 | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02069 | |
0.4403 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 |